Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Forest Labs buyout may boost other drug stocks
USA Today
Tuesday, February 18, 2014 - 3:40pm
tags:
Forest Labs, M&A, Actavis
Neuralstem Phase 1 Data Gives Hope In ALS
Seeking Alpha
Tuesday, February 18, 2014 - 3:38pm
tags:
Neuralstem, amyotrophic lateral sclerosis, ALS, NSI-566
Dendreon: The Time Is Now
Seeking Alpha
Tuesday, February 18, 2014 - 11:33am
tags:
Dendreon, JNJ, Provenge, Medivation
Billionaire Teva Chairman May Retire by Year’s End
Bloomberg
Tuesday, February 18, 2014 - 10:36am
tags:
Teva Pharmaceuticals, Phillip Frost
Novimmune banks $66M for immunotherapies as IPO rumors surface
Fierce Biotech
Tuesday, February 18, 2014 - 10:35am
tags:
IPOs, Novimmune, monoclonal antibodies
Bayer cites success in hemophilia study, but may still trail Biogen Idec
Fierce Biotech
Tuesday, February 18, 2014 - 10:33am
tags:
Bayer, Biogen Idec, hemophilia, BAY94-9027, Factor VIII
Straightening Out Auxilium Pharma's Value
Seeking Alpha
Tuesday, February 18, 2014 - 10:21am
tags:
Auxilium
Immune Checkpoint Blocker Race Heats Up
Wall St Cheat Sheet
Tuesday, February 18, 2014 - 10:19am
tags:
immune checkpoint blockers, Yervoy, Bristol-Myers Squibb, MK-3475, Merck
Actavis confirms $25 bln Forest Labs acquistion
Marketwatch
Tuesday, February 18, 2014 - 9:13am
tags:
Actavis, M&A, Forest Labs
2014 Could Be A Transformative Year For Apricus Biosciences
Seeking Alpha
Tuesday, February 18, 2014 - 9:11am
tags:
Apricus Biosciences, Vitaros, erectile dysfunction, Femprox, female sexual dysfunction
Enzymotec Had A Great 2013, And Has A Promising Year Ahead
Seeking Alpha
Tuesday, February 18, 2014 - 9:01am
tags:
Enzmotec, infant nutrtion
Galena CEO's Response to Stock Promotions Leaves Questions Unanswered
TheStreet.com
Tuesday, February 18, 2014 - 9:00am
tags:
Galena Biopharma, Pharma CEOs, Mark Ahn
Preclinical Study Results of Merrimack's MM-141 Published in Molecular Cancer Therapeutics
Yahoo/Benzinga
Tuesday, February 18, 2014 - 8:58am
tags:
Merrimack Pharmaceuticals, MM-141
3 Great Small-Cap Biotech Stocks: NeoStem, Pozen, Curis
Wall St Cheat Sheet
Tuesday, February 18, 2014 - 8:57am
tags:
NeoStem, Pozen, Curis
Medtronic posts lower earnings on charges
Yahoo/Reuters
Tuesday, February 18, 2014 - 8:56am
tags:
Medtronic, earnings, devices
FDA head says working with India to improve drug quality, safety
Yahoo/Reuters
Tuesday, February 18, 2014 - 8:55am
tags:
FDA, India, quality, drug manufacturing
Actavis in talks to buy Forest Labs for as much as $25 billion - WSJ
Yahoo/Reuters
Tuesday, February 18, 2014 - 8:54am
tags:
Actavis, Forest Labs, M&A
Big Pharma Continues the Race for Electroporation
Wall St Cheat Sheet
Monday, February 17, 2014 - 8:02pm
tags:
electroporation, Roche, Pfizer, Inovio, Ichor
BioMarin and its patient coaches are ready to roll on Vimizim launch
Fierce Pharma
Monday, February 17, 2014 - 7:48pm
tags:
Biomarin, Vimizim, drug launches
ViiV, Gilead sweep the pharma image competition--and Pfizer is close behind
Fierce Pharma
Monday, February 17, 2014 - 7:47pm
tags:
Gilead Sciences, ViiV, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.